---
category: news
title: "REALM IDx™ to Participate Virtually in the 40th Annual J.P. Morgan Health Care Conference"
excerpt: "REALM IDx, Inc., a leader in integrated diagnostics, announced the company will participate in the upcoming 40th Annual J.P. Morgan Health Care Conference. This premier health care conference features global industry leaders,"
publishedDateTime: 2022-01-06T23:57:00Z
originalUrl: "https://apnews.com/press-release/pr-newswire/technology-health-ff232c02aa05615ba640af196270be1d"
webUrl: "https://apnews.com/press-release/pr-newswire/technology-health-ff232c02aa05615ba640af196270be1d"
type: article
quality: 15
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "Insilico Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference"
    excerpt: "Insilico Medicine (\"Insilico\"), an end-to-end artificial intelligence (AI)-driven drug discovery company, will virtually participate in the 40th Annual J.P. Morgan Healthcare Conference. Alex Zhavoronkov,"
    publishedDateTime: 2022-01-07T10:55:00Z
    webUrl: "https://us.acrofan.com/detail.php?number=596729"
    type: article
    provider:
      name: 아크로팬
      domain: acrofan.com
    quality: 34
    images:
      - url: "http://us.acrofan.com/img/noImg.jpg"
        width: 500
        height: 324
        isCached: true
  - title: "Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets"
    excerpt: "This strategic collaboration includes an AI-driven drug discovery research and development (R&D) collaboration on four biological targets, as well as the co-development of Insilico's QPCTL program. Insilico will receive a total upfront payment of $13 million for the R&D collaboration projects and the co-development of the QPCTL program,"
    publishedDateTime: 2022-01-11T08:30:00Z
    webUrl: "https://www.prnewswire.com/in/news-releases/fosun-pharma-and-insilico-medicine-announce-a-strategic-ai-driven-drug-discovery-and-development-collaboration-to-jointly-advance-multiple-targets-829629042.html"
    type: article
    provider:
      name: PR Newswire
      domain: prnewswire.com
    quality: 1
    images:
      - url: "https://mma.prnewswire.com/media/1723121/Fosun.jpg?p=facebook"
        width: 1268
        height: 664
        isCached: true

secured: "WtI59SUnDXvXlkwem2f8Hi6KrbIQGoVwNsve0R4OTcOtkBY2ptuVyMSyU46eQrpzkSJCRZRlrwIrolDhOXylbkyqGE/ftxVx/RFkLMNDcasOWquE8ZSsF4+e4aqbXewKiniiNuZ8VcyIzirT2NFYDuFuqzPsQpZqG8Zxxkt1DUuJvB5DYC8752SL7/hmCKeEs8A6K0iq9qL9t8cd8tEq9JN+ytTFldaFxp65809BFkpJJpCzFHUEYSb4T94Lrg6yrza04N+FGYLEDObJyANrJssouhz9RHDZ0yp6dCl5erM5yDGNGe68u10w1hM7yHCJvfd658XoLxhBw/TA6wYvvRv9yz8gN5S3C1faG03lGCg=;44v4sG0IDrCgldGzQd8dew=="
---

